Benzinga's Top #PreMarket Gainers

Medivation (NASDAQ: MDVN ) soared 21.40% to $92.00 in the pre-market trading after the company and Astellas reported final results from the Phase 3 PREVAIL trial of Enzalutamide. AudioCodes (NASDAQ: AUDC ) shares jumped 7.37% to $7.43 in pre-market trading after the company reported Q4 results. The Dow Chemical Company